Credit rating
Company information
About Dr. Faustus ApS
Dr. Faustus ApS (CVR number: 43747657) is a company from GENTOFTE. The company recorded a gross profit of 0 kDKK in 2023. The operating profit was -713.2 kDKK, while net earnings were 619.2 kDKK. The profitability of the company measured by Return on Assets (ROA) was 76.7 %, which can be considered excellent and Return on Equity (ROE) was 93.9 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 63.6 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. Dr. Faustus ApS's liquidity measured by quick ratio was 2.7 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2023 | |
---|---|
Volume | |
Net sales | |
Gross profit | |
EBIT | - 713.23 |
Net earnings | 619.21 |
Shareholders equity total | 659.21 |
Balance sheet total (assets) | 1 036.08 |
Net debt | - 430.35 |
Profitability | |
EBIT-% | |
ROA | 76.7 % |
ROE | 93.9 % |
ROI | 120.5 % |
Economic value added (EVA) | - 556.25 |
Solvency | |
Equity ratio | 63.6 % |
Gearing | |
Relative net indebtedness % | |
Liquidity | |
Quick ratio | 2.7 |
Current ratio | 2.7 |
Cash and cash equivalents | 430.35 |
Capital use efficiency | |
Trade debtors turnover (days) | |
Net working capital % | |
Credit risk | |
Credit rating | B |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.